U.S. Personal Products Stock News

Brookfield Infrastructure Partners reported its second quarter 2025 results, posting sales of US$5.43 billion and reducing its net loss to US$6 million compared to the previous year, while also announcing a 6% increase in its quarterly distribution to US$0.43 per unit, with affirmations for several preferred dividends. This combination of stable operating results and a higher distribution marks a continued focus on shareholder returns despite only modest changes in net profitability. We'll...

Arthur J. Gallagher & Co. recently reported its second quarter 2025 results, with revenue rising to US$3.22 billion and net income reaching US$365.8 million, both up from the same period last year; the company also reaffirmed its regular quarterly cash dividend. Despite having an existing share repurchase authorization, Arthur J. Gallagher did not buy back any shares in the latest reported period, highlighting a focus on reinvestment and capital returns via dividends instead of...

ArcBest Corporation recently reported results for the second quarter and first half of 2025, showing year-over-year declines in sales to US$1,022.26 million and net income to US$25.81 million for the quarter, alongside completion of a share buyback covering nearly 27% of total shares since 2003. This demonstrates how operational and profitability pressures have persisted, even as the company continued to repurchase shares in support of shareholder value. We'll explore how ArcBest’s softer...

Wave Life Sciences Ltd. recently reported its second quarter 2025 results, disclosing sales of US$8.7 million and a net loss of US$50.47 million, both adversely affected compared to the same period last year. The company’s basic loss per share from continuing operations increased to US$0.31, reflecting growing expenses and a less robust revenue stream during the period. We'll examine how the sharp year-over-year drop in quarterly sales may alter Wave Life Sciences' investment narrative and...

Earlier this month, Rheinmetall Landsysteme Germany announced Curtiss-Wright will supply modular turret drive stabilization systems for the KF51 Panther Main Battle Tank, and Curtiss-Wright also expanded its 2025 share repurchase program by US$200 million, bringing expected annual buybacks to US$266 million. This combination of a significant new defense technology contract and a stepped-up capital return program highlights Curtiss-Wright’s focus on growth and shareholder returns through...

Sweetgreen, Inc. recently reported second-quarter 2025 results, with sales of US$185.58 million and a net loss of US$23.16 million, alongside updated full-year guidance forecasting revenue between US$700 million and US$715 million and a same-store sales decline of 6% to 4%. While Sweetgreen expects at least 40 new restaurant openings in 2025, including 20 Infinite Kitchen locations, its guidance highlights pressure on same-store sales growth and profitability. To assess how Sweetgreen’s...

Novasign announced in late July 2025 that it has entered into a partnership with Repligen Corporation to integrate its machine learning and modeling workflow into Repligen's tangential flow filtration (TFF) systems, with Repligen also investing in Novasign to support its growth. This collaboration introduces advanced analytics capabilities to Repligen's filtration systems, enabling more efficient process development and potentially addressing critical industry needs for faster, lower-risk,...

ARMOUR Residential REIT, Inc. recently completed a follow-on equity offering of 18,500,000 common shares, raising approximately US$302.48 million after amending its authorized share count from 125,000,000 to 175,000,000 shares. This sequence of actions expands the company's financial flexibility and alters its future capital structure and potential growth trajectory. We'll explore how ARMOUR Residential REIT's expanded authorized shares and completed equity offering shape its overall...

Pulse Biosciences recently reported a net loss of US$19.17 million for the second quarter ended June 30, 2025, alongside updates on its nsPFA technology programs and regulatory progress. The company is advancing key clinical milestones, including expanding its pilot program for soft tissue ablation and preparing for pivotal trials in atrial fibrillation and benign thyroid disease. We'll examine how the expanded pilot program for the nsPFA Percutaneous Electrode influences Pulse Biosciences’...

Azenta, Inc. reported its third quarter fiscal 2025 results, showing revenue of US$143.94 million and a net loss of US$52.81 million, alongside a reaffirmed guidance for 3% to 5% organic revenue growth for the year. Additionally, Azenta announced a new collaboration with Frenova and Nephronomics to provide genomic sequencing for a major genomics research program focused on cardio-kidney-metabolic diseases. We’ll now explore how Azenta’s reaffirmed growth outlook could influence its...

Regal Rexnord reported second quarter results that met revenue expectations and delivered stronger year-over-year earnings, updated its 2025 earnings guidance, and announced a new partnership with ABB Robotics to advance its automation offerings, while also confirming a key executive transition set for the end of the year. The collaboration with ABB Robotics, enabling Regal Rexnord’s Thomson Movotrak CTU to become the first certified 7th axis technology for ABB cobots, highlights the...

Genworth Financial reported second quarter 2025 results, noting net income of US$51 million, a decrease from US$76 million in the prior year's quarter, and announced that it completed repurchasing over 108 million shares for US$629.96 million since launching its buyback in May 2022. This substantial buyback represents nearly a quarter of outstanding shares, highlighting the company's commitment to returning capital to shareholders during a period of lower net earnings. We'll examine how...

On August 7, 2025, UWM Holdings Corporation announced its second quarter results, reporting revenue of US$758.7 million and net income of US$22.91 million, both higher than the prior year, along with third quarter guidance of production between US$33 billion and US$40 billion and a gain margin of 100 to 125 basis points; the company also affirmed a US$0.10 per share cash dividend for October 2025. The combination of stronger year-over-year earnings, forward-looking operational guidance, and...

Janux Therapeutics recently announced the dosing of the first patient in its TRACTr collaboration program with Merck, triggering a US$10 million milestone payment and highlighting clinical progress across its pipeline, including Phase 1 trials for JANX007 and JANX008. This milestone underscores the continued momentum in Janux’s innovative bispecific product pipeline for oncology and potential therapies for autoimmune diseases. We'll explore how clinical progress and milestone payments from...

Astec Industries announced its second quarter 2025 results, reporting US$330.3 million in sales and a swing to net income of US$16.7 million from a net loss in the prior year, alongside a new shelf registration for over US$52.8 million in common stock. Despite a year-over-year drop in quarterly sales, the company's turnaround to profitability suggests improved cost control or operational efficiency played a crucial role this period. We’ll examine how Astec Industries’ return to profit after...

Smurfit Westrock reported second quarter 2025 earnings, showing sales of US$7.94 billion and a net loss of US$28 million, with the board also affirming a quarterly dividend of US$0.4308 per share. The sharp jump in sales reflects the impact of the recent merger, while enduring a quarterly loss suggests integration and cost challenges were still present during the period. We'll explore how the company's decision to maintain its dividend amid a quarterly net loss influences the longer-term...

Marqeta, Inc. recently reported second quarter 2025 results, with quarterly sales reaching US$150.39 million, up from US$125.27 million a year earlier, while moving from a net income of US$119.11 million last year to a small net loss of US$647,000. The company also raised its full-year 2025 revenue growth outlook following strong transaction volume growth across core lending and expense management verticals, despite some macroeconomic uncertainties. We’ll now explore how Marqeta’s upgraded...

In the past week, Quaker Chemical Corporation reported second quarter results, posting sales of US$483.4 million and a net loss of US$66.58 million, primarily due to an US$88.8 million goodwill impairment charge in its EMEA segment. Despite a dividend increase and completing a share repurchase program, Quaker Chemical's results reflected ongoing economic headwinds and a significant decline in profitability compared to last year. We'll explore how the goodwill impairment and weak earnings...

Capri Holdings Limited recently reported its first quarter results for fiscal 2026, posting net income of US$53 million on sales of US$797 million, a return to profitability compared to a loss a year ago, and issued new revenue and earnings guidance for the next quarter and full year. Shortly after, Capri Holdings also filed a US$52.1 million shelf registration for 2.5 million ordinary shares in an ESOP-related offering, suggesting a focus on employee engagement and potential changes to its...

SiTime Corporation recently reported its second quarter results with sales of US$69.49 million and a reduced net loss of US$20.18 million compared to the previous year, while also issuing third quarter revenue guidance of US$77 million to US$79 million. A key insight is that the company not only delivered substantial year-over-year revenue growth, but also indicated an expectation of further improvement in the upcoming quarter, signaling continued momentum in its business performance. We'll...

Cabot Corporation recently reported third-quarter fiscal 2025 earnings above analyst expectations, with adjusted earnings per share reaching US$1.90 despite a 9.2% year-over-year decline in net sales to US$923 million. In addition to reaffirming its fiscal 2025 guidance, Cabot has outlined plans for acquisitions and investments targeting growth areas such as batteries and conductive materials, while highlighting robust cash flow and a disciplined capital allocation approach. We'll explore...

Intellia Therapeutics recently announced that Dr. David Lebwohl, its Executive Vice President and Chief Medical Officer, will retire effective August 7, 2026, and also reported second quarter 2025 financial results showing a reduced net loss year-over-year. The decrease in net loss, both for the quarter and the first half of the year, stands out as a significant shift in the company’s financial trajectory. We’ll explore how the improved quarterly loss positions Intellia Therapeutics within...

EchoStar Corporation recently reported its second quarter 2025 financial results, revealing revenue of US$3.72 billion and a net loss of US$306.13 million, both down from the same period last year. These results show EchoStar's losses per share and revenue declines have accelerated, increasing pressure on the company's ongoing turnaround efforts. Given these wider losses and reduced revenues, we'll examine how this may impact EchoStar's investment narrative and outlook. The end of cancer?...

In recent announcements, 180 Life Sciences Corp. reported the completion of very large private placements, raising over US$425 million through common share and pre-funded warrant offerings, alongside the issuance of US$156.25 million in convertible notes to an institutional investor. A simultaneous overhaul in board composition introduced directors with extensive experience in finance, energy, and capital markets, signaling a potential evolution in the company’s operational focus and market...